Perceived Barriers and Facilitators of Using Synchronous Telerehabilitation of Physical and Occupational Therapy in Musculoskeletal Disorders: A Scoping Review

Abstract

Purpose: Physical and occupational therapy interventions are increasingly delivered through videoconferencing to overcome barriers related to face-to-face delivery. The objective of this scoping review was to identify barriers and facilitators of using synchronous telerehabilitation to deliver these interventions for musculoskeletal disorders. Materials and Methods: MEDLINE, EMBASE, PsycInfo, CINAHL, Cochrane Library, and ProQuest Dissertations and Theses databases were searched in May 2020. Qualitative and quantitative studies in any language that described barriers and facilitators of using synchronous videoconferencing for physical or occupational interventions or assessments for individuals with musculoskeletal diseases were eligible. Results: Twenty-three publications were included that reported 59 facilitators and 41 barriers to using telerehabilitation. All included studies (100%) reported on facilitators, and 20 (87%) studies also reported on barriers. Most commonly reported facilitators included convenience and accessibility of services, audio and visual quality, and financial and time savings. Most commonly reported barriers included technological issues, privacy concerns, impersonal connection, and difficulty establishing rapport between patients and healthcare professionals. Conclusions: Factors including quality and user-friendliness may facilitate the delivery of physical or occupational therapy interventions or assessments for musculoskeletal diseases using telerehabilitation. Strategies to address key barriers should be considered when developing and implementing such interventions or assessments.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by an Edith Strauss Project Grant. Ms. Carboni-Jiménez was supported by a McGill University Faculty of Medicine Solvay Fellowship and by a McGill University Delta Upsilon Scholarship. Dr. Thombs was supported by a Tier 1 Canada Research Chair.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

No data were produced for this scoping review (use of published data only)

留言 (0)

沒有登入
gif